Abstract
and PurposeWe tested the hypothesis that administration of 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a potent sigma-receptor ligand, during transient focal ischemia would affect early postischemic brain injury. MethodsHalothane-anesthetized cats underwent left middle cerebral artery occlusion for 90 minutes followed by 4 hours of reperfusion. Control cats received saline (n equals 10). Experimental cats (2 groups, n equals 10 per group) were treated with PPBP at a rate of 0.1 mu mol/kg per hour (PPBP-0.1) or administered 1 mu mol/kg per hour (PPBP-1) intravenously from 75 minutes after initiation of ischemia and continuing during the 4 hours of reperfusion. ResultsAs measured by the microsphere method, blood flow to the ipsilateral caudate nucleus was decreased similarly in all groups during ischemia. Blood flow to the ipsilateral inferior temporal cortex was decreased during ischemia in all groups but was higher in cats subsequently treated with PPBP at the highest dose, even before drug administration. There was no difference in blood flow to the ipsilateral caudate nucleus or inferior temporal cortex (area of greatest cortical injury) during reperfusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral hemisphere (control, 29 plus minus 5%; PPBP-0.1, 17 plus minus 3%; PPBP-1, 6 plus minus 1% of ipsilateral hemisphere; mean plus minus SEM) and caudate nucleus (control, 49 plus minus 5%; PPBP-0.1, 39 plus minus 6%; PPBP-1, 25 plus minus 5% of ipsilateral caudate nucleus) was less in cats treated with 1 mu mol/kg per hour of PPBP compared with cats treated with saline. Cats treated with 0.1 mu mol/kg per hour had a 45% smaller hemispheric injury volume than the control group without differences in intraischemic blood flow. Recovery of somatosensory evoked potential amplitude was greater in cats treated with PPBP-1 compared with control (control, 18 plus minus 11%; PPBP-0.1, 30 plus minus 14%; PPBP-1, 54 plus minus 14% of baseline). ConclusionsThese data indicate that sigma-receptors may play an important role in the mechanism of acute injury in both the cortex and the caudate nucleus after 90 minutes of transient focal ischemia in the cat. Because PPBP afforded protection when administered at the end of ischemia and during reperfusion, sigma-receptors may contribute to the progression of injury in ischemic border regions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1676-1682 |
| Number of pages | 7 |
| Journal | Stroke |
| Volume | 26 |
| Issue number | 9 |
| State | Published - 1995 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Clinical Neurology
- Advanced and Specialized Nursing
- Neuroscience(all)
Cite this
Ppbp [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats. / Takahashi, Hiroshi; Kirsch, Jeffrey; Hashimoto, Kenji; London, Edythe D.; Koehler, Raymond C.; Traystman, Richard J.
In: Stroke, Vol. 26, No. 9, 1995, p. 1676-1682.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Ppbp [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats
AU - Takahashi, Hiroshi
AU - Kirsch, Jeffrey
AU - Hashimoto, Kenji
AU - London, Edythe D.
AU - Koehler, Raymond C.
AU - Traystman, Richard J.
PY - 1995
Y1 - 1995
N2 - and PurposeWe tested the hypothesis that administration of 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a potent sigma-receptor ligand, during transient focal ischemia would affect early postischemic brain injury. MethodsHalothane-anesthetized cats underwent left middle cerebral artery occlusion for 90 minutes followed by 4 hours of reperfusion. Control cats received saline (n equals 10). Experimental cats (2 groups, n equals 10 per group) were treated with PPBP at a rate of 0.1 mu mol/kg per hour (PPBP-0.1) or administered 1 mu mol/kg per hour (PPBP-1) intravenously from 75 minutes after initiation of ischemia and continuing during the 4 hours of reperfusion. ResultsAs measured by the microsphere method, blood flow to the ipsilateral caudate nucleus was decreased similarly in all groups during ischemia. Blood flow to the ipsilateral inferior temporal cortex was decreased during ischemia in all groups but was higher in cats subsequently treated with PPBP at the highest dose, even before drug administration. There was no difference in blood flow to the ipsilateral caudate nucleus or inferior temporal cortex (area of greatest cortical injury) during reperfusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral hemisphere (control, 29 plus minus 5%; PPBP-0.1, 17 plus minus 3%; PPBP-1, 6 plus minus 1% of ipsilateral hemisphere; mean plus minus SEM) and caudate nucleus (control, 49 plus minus 5%; PPBP-0.1, 39 plus minus 6%; PPBP-1, 25 plus minus 5% of ipsilateral caudate nucleus) was less in cats treated with 1 mu mol/kg per hour of PPBP compared with cats treated with saline. Cats treated with 0.1 mu mol/kg per hour had a 45% smaller hemispheric injury volume than the control group without differences in intraischemic blood flow. Recovery of somatosensory evoked potential amplitude was greater in cats treated with PPBP-1 compared with control (control, 18 plus minus 11%; PPBP-0.1, 30 plus minus 14%; PPBP-1, 54 plus minus 14% of baseline). ConclusionsThese data indicate that sigma-receptors may play an important role in the mechanism of acute injury in both the cortex and the caudate nucleus after 90 minutes of transient focal ischemia in the cat. Because PPBP afforded protection when administered at the end of ischemia and during reperfusion, sigma-receptors may contribute to the progression of injury in ischemic border regions.
AB - and PurposeWe tested the hypothesis that administration of 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a potent sigma-receptor ligand, during transient focal ischemia would affect early postischemic brain injury. MethodsHalothane-anesthetized cats underwent left middle cerebral artery occlusion for 90 minutes followed by 4 hours of reperfusion. Control cats received saline (n equals 10). Experimental cats (2 groups, n equals 10 per group) were treated with PPBP at a rate of 0.1 mu mol/kg per hour (PPBP-0.1) or administered 1 mu mol/kg per hour (PPBP-1) intravenously from 75 minutes after initiation of ischemia and continuing during the 4 hours of reperfusion. ResultsAs measured by the microsphere method, blood flow to the ipsilateral caudate nucleus was decreased similarly in all groups during ischemia. Blood flow to the ipsilateral inferior temporal cortex was decreased during ischemia in all groups but was higher in cats subsequently treated with PPBP at the highest dose, even before drug administration. There was no difference in blood flow to the ipsilateral caudate nucleus or inferior temporal cortex (area of greatest cortical injury) during reperfusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral hemisphere (control, 29 plus minus 5%; PPBP-0.1, 17 plus minus 3%; PPBP-1, 6 plus minus 1% of ipsilateral hemisphere; mean plus minus SEM) and caudate nucleus (control, 49 plus minus 5%; PPBP-0.1, 39 plus minus 6%; PPBP-1, 25 plus minus 5% of ipsilateral caudate nucleus) was less in cats treated with 1 mu mol/kg per hour of PPBP compared with cats treated with saline. Cats treated with 0.1 mu mol/kg per hour had a 45% smaller hemispheric injury volume than the control group without differences in intraischemic blood flow. Recovery of somatosensory evoked potential amplitude was greater in cats treated with PPBP-1 compared with control (control, 18 plus minus 11%; PPBP-0.1, 30 plus minus 14%; PPBP-1, 54 plus minus 14% of baseline). ConclusionsThese data indicate that sigma-receptors may play an important role in the mechanism of acute injury in both the cortex and the caudate nucleus after 90 minutes of transient focal ischemia in the cat. Because PPBP afforded protection when administered at the end of ischemia and during reperfusion, sigma-receptors may contribute to the progression of injury in ischemic border regions.
UR - http://www.scopus.com/inward/record.url?scp=0029145972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029145972&partnerID=8YFLogxK
M3 - Article
C2 - 7544928
AN - SCOPUS:0029145972
VL - 26
SP - 1676
EP - 1682
JO - Stroke
JF - Stroke
SN - 0039-2499
IS - 9
ER -